About Merus Labs International (TSE:MSL)
Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.
Industry, Sector and Symbol
Trailing P/E Ratio-15
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-2.51%
Return on Assets-1.32%
Merus Labs International (TSE:MSL) Frequently Asked Questions
What is Merus Labs International's stock symbol?
Merus Labs International trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MSL."
Where is Merus Labs International's stock going? Where will Merus Labs International's stock price be in 2018?
1 brokers have issued 12-month price targets for Merus Labs International's stock. Their predictions range from C$1.65 to C$1.65. On average, they anticipate Merus Labs International's stock price to reach C$1.65 in the next year. View Analyst Ratings for Merus Labs International.
Who are some of Merus Labs International's key competitors?
Some companies that are related to Merus Labs International include Royal Bank of Canada (RY), Toronto-Dominion Bank (TD), Bank of Nova Scotia (BNS), Canadian National Railway (CNR), Enbridge (ENB), Suncor Energy (SU), Bank of Montreal (BMO), Canadian Imperial Bank of Commerce (CM), Brookfield Asset Management (BAM.A), BCE (BCE), TransCanada (TRP), Manulife Financial (MFC), Canadian Natural Resources (CNQ), Thomson Reuters (TRI), Alimentation Couche-Tard (ATD.A), Alimentation Couche-Tard (ATD.B), Restaurant Brands International (QSR) and Great-West Lifeco (GWO).
Who are Merus Labs International's key executives?
Merus Labs International's management team includes the folowing people:
- Michael S. Cloutier, Independent Chairman of the Board
- Barry Fishman, Chief Executive Officer, Director
- Michael Scott Bumby, Chief Financial Officer
- Robert McLay, Vice President - Sales and Marketing
- Frank Rotmann, Vice President and Head of European Operations
- Robert Bloch M.D., Director
- Theresa Sheila Firestone, Independent Director
- David D. Guebert CPA, Independent Director
- Robert S. Pollock, Independent Director
- Timothy G. Sorensen, Independent Director
Has Merus Labs International been receiving favorable news coverage?
News stories about MSL stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Merus Labs International earned a news impact score of 0.01 on Accern's scale. They also assigned news articles about the specialty pharmaceutical company an impact score of 45.98 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Merus Labs International?
Shares of MSL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How can I contact Merus Labs International?
Merus Labs International's mailing address is 100 Wellington St. West Suite 2110 Stn Toronto Dom PO Box 151, TORONTO, ON M5K 1H1, Canada. The specialty pharmaceutical company can be reached via phone at +1-905-7260995.
MarketBeat Community Rating for Merus Labs International (MSL)MarketBeat's community ratings are surveys of what our community members think about Merus Labs International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Merus Labs International (TSE:MSL) Earnings History and Estimates Chart
Merus Labs International (TSE MSL) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/11/2017||Q2 2017||C($0.01)||C($0.01)||C$27.79 million||C$22.65 million||View||N/A|
|2/14/2017||Q1 2017||C($0.03)||C($0.05)||C$27.40 million||C$26.07 million||View||N/A|
|8/15/2016||Q3 2016||C($0.04)||C$26.74 million||C$25.66 million||View||N/A|
|5/11/2016||Q2 2016||C$0.01||C($0.01)||C$23.92 million||C$19.70 million||View||N/A|
|2/11/2016||Q1 2016||C($0.01)||C($0.01)||C$15.79 million||C$15.93 million||View||N/A|
|12/7/2015||Q4 2015||C$0.01||C$0.01||C$15.20 million||C$16.14 million||View||N/A|
|8/10/2015||Q3 2015||C$0.02||C($0.02)||C$15.82 million||C$9.51 million||View||N/A|
|5/13/2015||Q2 2015||C$0.03||C$12.68 million||View||N/A|
|12/18/2014||Q4 2014||C($0.06)||C$8.05 million||C$6.02 million||View||N/A|
|5/14/2014||Q2 2014||C$0.01||C($0.04)||C$7.00 million||C$6.69 million||View||N/A|
|2/14/2014||Q1 2014||C($0.05)||C$6.80 million||C$6.26 million||View||N/A|
|12/30/2013||Q4 2013||C$0.02||C$9.13 million||View||N/A|
|8/13/2013||Q3 2013||C($0.03)||C$7.50 million||C$7.32 million||View||N/A|
|5/14/2013||Q2 2013||C($0.07)||C$6.20 million||C$5.85 million||View||N/A|
Merus Labs International (TSE:MSL) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Merus Labs International (TSE:MSL)
No dividend announcements for this company have been tracked by MarketBeat.com
Merus Labs International (TSE MSL) Insider Trading and Institutional Ownership History
Merus Labs International (TSE MSL) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Merus Labs International (TSE MSL) News Headlines
Merus Labs International (TSE:MSL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Merus Labs International (TSE MSL) Stock Chart for Sunday, March, 18, 2018